Compounds > clopidogrel

clopidogrel and Staphylococcal Infections

clopidogrel has been researched along with Staphylococcal Infections in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's3 (100.00)2.80

Authors

AuthorsStudies
Appaneal, HJ; Caffrey, AR; LaPlante, KL; Lopes, VV; Nizet, V; Sakoulas, G; Ulloa, ER1
Gentry, CA; Kliewer, BS; Thind, SK; Whitman, CM; Williams, RJ2

Other Studies

3 other study(ies) available for clopidogrel and Staphylococcal Infections

ArticleYear
Impact of Clopidogrel on Clinical Outcomes in Patients with Staphylococcus aureus Bacteremia: a National Retrospective Cohort Study.
    Antimicrobial agents and chemotherapy, 2022, 06-21, Volume: 66, Issue:6

    Topics: Anti-Bacterial Agents; Bacteremia; Clopidogrel; Cohort Studies; Humans; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Thrombocytopenia

2022
Staphylococcus aureus bacteraemia treatment outcomes in patients receiving ticagrelor vs a propensity-matched cohort receiving clopidogrel.
    International journal of antimicrobial agents, 2023, Volume: 61, Issue:4

    Topics: Bacteremia; Clopidogrel; Humans; Platelet Aggregation Inhibitors; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Ticagrelor; Treatment Outcome

2023
Propensity-matched analysis of the protective effect of ticagrelor versus clopidogrel on the risk of developing Staphylococcus aureus bacteremia.
    International journal of antimicrobial agents, 2023, Volume: 61, Issue:4

    Topics: Acute Coronary Syndrome; Clopidogrel; Humans; Platelet Aggregation Inhibitors; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Ticagrelor; Treatment Outcome

2023